$18.99
-0.170 (-0.89%)
At Close: Jun 03, 2026
HQH: Put Some Assets In Defensive Names With Growth Potential
12:00am, Thursday, 07'th Feb 2019Oculis Raises CHF15.5M in Extension of Series B Financing | FinSMEs
12:22pm, Friday, 04'th Jan 2019
Oculis, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments, raised a further CHF15.5m in Series B financing
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
12:00am, Monday, 17'th Dec 2018Milestone Pharmaceuticals Raises $80M in Equity Funding | FinSMEs
04:08pm, Thursday, 25'th Oct 2018
Milestone Pharmaceuticals, a Montreal, Canada-based late-stage biopharma company developing interventions for tachycardias, completed an $80m financing
Sign In
Buy HQH